MEPHENYTOIN AND SPARTEINE OXIDATION - GENETIC POLYMORPHISMS IN DENMARK

被引：44

作者：

DROHSE, A ^{[1
]}

BATHUM, L ^{[1
]}

BROSEN, K ^{[1
]}

GRAM, LF ^{[1
]}

机构：

[1] ODENSE UNIV,DEPT CLIN PHARMACOL,JB WINSLOWS VEJ 19,DK-5000 ODENSE C,DENMARK

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 27卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.1989.tb03426.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：620 / 625

页数：6

相关论文

共 19 条

[1] BERTILSSON L, 1989, IN PRESS CLIN PHARM
[2] BREIMER DA, 1988, 7TH P INT S MICR DRU, P232
[3] BROSEN K, 1985, ACTA PHARMACOL TOX, V57, P357
[4] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS
CLARK, DWJ
[J]. DRUGS, 1985, 29 (04) : 342 - 375
[5] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
EICHELBAUM, M
SPANNBRUCKER, N
STEINCKE, B
DENGLER, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
[6] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION
EVANS, DAP
MAHGOUB, A
SLOAN, TP
IDLE, JR
SMITH, RL
[J]. JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) : 102 - 105
[7] CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM
GONZALEZ, FJ
SKODA, RC
KIMURA, S
UMENO, M
ZANGER, UM
NEBERT, DW
GELBOIN, HV
HARDWICK, JP
MEYER, UA
[J]. NATURE, 1988, 331 (6155) : 442 - 446
[8] MEPHENYTOIN AND SPARTEINE PHARMACOGENETICS IN CANADIAN CAUCASIANS
INABA, T
JURIMA, M
NAKANO, M
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) : 670 - 676
[9] INABA T, 1986, AM J HUM GENET, V38, P768
[10] GENETIC-POLYMORPHISM OF MEPHENYTOIN P(4')-HYDROXYLATION - DIFFERENCE BETWEEN ORIENTALS AND CAUCASIANS
JURIMA, M
INABA, T
KADAR, D
KALOW, W
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (04) : 483 - 487